ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Lucid Diagnostics Inc

Lucid Diagnostics Inc (LUCD)

0.9579
0.034
(3.68%)
Closed February 02 4:00PM
0.9615
0.0036
(0.38%)
After Hours: 7:57PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.9615
Bid
0.9304
Ask
0.9615
Volume
390,210
0.9188 Day's Range 0.9609
0.6301 52 Week Range 1.50
Market Cap
Previous Close
0.9239
Open
0.9299
Last Trade Time
Financial Volume
$ 371,063
VWAP
0.950933
Average Volume (3m)
452,910
Shares Outstanding
59,342,479
Dividend Yield
-
PE Ratio
-1.08
Earnings Per Share (EPS)
-0.89
Revenue
2.43M
Net Profit
-52.67M

About Lucid Diagnostics Inc

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically hig... Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Wilmington, Delaware, USA
Founded
-
Lucid Diagnostics Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LUCD. The last closing price for Lucid Diagnostics was $0.92. Over the last year, Lucid Diagnostics shares have traded in a share price range of $ 0.6301 to $ 1.50.

Lucid Diagnostics currently has 59,342,479 shares outstanding. The market capitalization of Lucid Diagnostics is $54.83 million. Lucid Diagnostics has a price to earnings ratio (PE ratio) of -1.08.

LUCD Latest News

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire NEW YORK, Jan. 13, 2025 Quarterly test volume of over 4,000 tests represented sequential increase of 45 percent NEW...

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule PR Newswire NEW YORK, Dec. 23, 2024 NEW YORK, Dec. 23, 2024 /PRNewswire/ -- Lucid...

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters PR Newswire NEW YORK, Dec. 19, 2024 Partnership launched with fully-contracted...

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication PR Newswire NEW YORK, Dec. 11, 2024 Study demonstrates outstanding...

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones PR Newswire NEW YORK, Dec. 3, 2024 New convertible debt...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.104512.19369894980.8570.9690.8422292453300.90535535CS
40.131515.8433734940.830.9690.78032066830.86688777CS
12-0.0385-3.8511.120.75014529100.89690682CS
260.161520.18750.81.120.72013188120.88160361CS
52-0.5385-35.91.51.50.63012490300.90230439CS
156-2.0385-67.9534.05980.63011385821.37880358CS
260-11.7885-92.458823529412.7513.50.63011549912.52109956CS

LUCD - Frequently Asked Questions (FAQ)

What is the current Lucid Diagnostics share price?
The current share price of Lucid Diagnostics is $ 0.9615
How many Lucid Diagnostics shares are in issue?
Lucid Diagnostics has 59,342,479 shares in issue
What is the market cap of Lucid Diagnostics?
The market capitalisation of Lucid Diagnostics is USD 54.83M
What is the 1 year trading range for Lucid Diagnostics share price?
Lucid Diagnostics has traded in the range of $ 0.6301 to $ 1.50 during the past year
What is the PE ratio of Lucid Diagnostics?
The price to earnings ratio of Lucid Diagnostics is -1.08
What is the cash to sales ratio of Lucid Diagnostics?
The cash to sales ratio of Lucid Diagnostics is 23.47
What is the reporting currency for Lucid Diagnostics?
Lucid Diagnostics reports financial results in USD
What is the latest annual turnover for Lucid Diagnostics?
The latest annual turnover of Lucid Diagnostics is USD 2.43M
What is the latest annual profit for Lucid Diagnostics?
The latest annual profit of Lucid Diagnostics is USD -52.67M
What is the registered address of Lucid Diagnostics?
The registered address for Lucid Diagnostics is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
Which industry sector does Lucid Diagnostics operate in?
Lucid Diagnostics operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCTMTCTM Kids IT Education Inc
$ 0.764
(321.87%)
731.1M
REBNReborn Coffee Inc
$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
$ 1.54
(56.50%)
13.87M
CYCNCyclerion Therapeutics Inc
$ 3.92
(54.33%)
82.57M
ENVBEnveric Biosciences Inc
$ 2.0899
(-46.41%)
1.57M
NIVFNewGenIvf Group Ltd
$ 0.1489
(-42.51%)
14.8M
GLSTGlobal Star Acquisition Inc
$ 8.83
(-39.10%)
23.89k
PRPHProPhase Labs Inc
$ 0.2633
(-38.02%)
872.46k
SPGCSacks Parente Golf Inc
$ 0.5601
(-37.86%)
7.27M
TCTMTCTM Kids IT Education Inc
$ 0.764
(321.87%)
729.72M
NVDANVIDIA Corporation
$ 120.07
(-3.67%)
388.54M
RIMEAlgorhythm Holdings Inc
$ 0.02565
(5.12%)
338.75M
BHATBlue Hat Interactive Entertainment Technology
$ 0.0355
(-11.25%)
236.29M
CLEUChina Liberal Education Holdings Ltd
$ 0.1938
(30.77%)
234.8M

LUCD Discussion

View Posts
georgie18 georgie18 3 months ago
LUCD...$1.08...Off my .90 alert...🥳

georgie18

Member Level
Re: georgie18 post# 384972

Thursday, November 07, 2024 8:57:15 AM

Post#
385327
of 385451
LUCD...$1.05...🥳...NEW YORK, Nov. 7, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that the manuscript for its multicenter ESOGUARD BE-1 study has been accepted for publication in The American Journal of Gastroenterology, the official journal of the American College of Gastroenterology (ACG). This is the fourth publication presenting clinical validation data for Lucid's EsoGuard® Esophageal DNA Test, and the second to demonstrate its strong performance in an intended-use screening population. Consistent with previous studies, EsoGuard showed high sensitivity and negative predictive value in detecting esophageal precancer (Barrett's Esophagus or BE).

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 9:48:42 AM

Post#
6
of 7
LUCD...9621...Trying Red to Green here...🥳

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 8:23:21 AM

Post#
384965
of 384971
LUCD...90 ...https://schrts.co/DyzNKhGQ ...Break/hold 98 and I think she will rip...🥳
👍️0
chemist72 chemist72 3 months ago
What is the MoIDX Medicare Program?
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=35025
👍️0
georgie18 georgie18 3 months ago
LUCD...$1.05...🥳...NEW YORK, Nov. 7, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that the manuscript for its multicenter ESOGUARD BE-1 study has been accepted for publication in The American Journal of Gastroenterology, the official journal of the American College of Gastroenterology (ACG). This is the fourth publication presenting clinical validation data for Lucid's EsoGuard® Esophageal DNA Test, and the second to demonstrate its strong performance in an intended-use screening population. Consistent with previous studies, EsoGuard showed high sensitivity and negative predictive value in detecting esophageal precancer (Barrett's Esophagus or BE).

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 9:48:42 AM

Post#
6
of 7
LUCD...9621...Trying Red to Green here...🥳

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 8:23:21 AM

Post#
384965
of 384971
LUCD...90 ...https://schrts.co/DyzNKhGQ ...Break/hold 98 and I think she will rip...🥳
👍️0
georgie18 georgie18 3 months ago
LUCD...9621...Trying Red to Green here...🥳

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 8:23:21 AM

Post#
384965
of 384971
LUCD...90 ...https://schrts.co/DyzNKhGQ ...Break/hold 98 and I think she will rip...🥳
👍️0
georgie18 georgie18 3 months ago
LUCD...90 ...https://schrts.co/DyzNKhGQ ...Break/hold 98 and I think she will rip...🥳
👍️0
Monksdream Monksdream 11 months ago
LUCD new 52 lo
👍️0
Monksdream Monksdream 1 year ago
LUCD new 52 week low
👍️0
ErnieBilco ErnieBilco 3 years ago
Should have listened to the chart telling me lower but I bought some at $2.39 and $2.21 for a starter. It has a $9+ PT
👍️0
makinezmoney makinezmoney 3 years ago
$LUCD: Not the EV Car Company...............


But you can easily get confused.



Now at $7.30 here in PreMarket



https://www.luciddx.com/





GO $LUCD
👍️0

Your Recent History

Delayed Upgrade Clock